|
Belief in a Mission...The PhRMA Foundation is lastingly indebted to a cadre of PhRMA Board members who despite uncommon demands on their time through the nature of their jobs have given more than three decades of faithful and sagacious service. They have done so, plainly, because they believed in what the Foundation was doing, and they believed in its potential for even greater performance in an essential mission.  Garry A. Neil, M.D. Chairman Corporate Vice President, Corporate Office of Science & Technology Johnson & Johnson Raritan, New Jersey
|  Ivan Gergel, M.D. Executive Vice President, R&D Endo Pharmaceuticals Chadds Ford, Pennsylvania |  Howard G. Hutchinson, M.D. Chief Medical Officer AstraZeneca Pharmaceuticals Inc. Wilmington, Delaware
|  Peter S. Kim, Ph.D. President Merck Research Laboratories Merck & Co. North Wales, Pennsylvania |  John M. Leonard, M.D. Vice President of Global Scientific and Medical Affairs Abbott Laboratories Abbott Park, Illinois |  Jan M. Lundberg,Ph.D. Executive Vice President, Science and Technology President, Lilly Research Laboratories Eli Lilly and Company Indianapolis, Indiana
|  Moncef Slaoui, Ph.D. Chairman, Research & Development GlaxoSmithKline King of Prussia, Pennsylvania
|  Billy Tauzin President and Chief Executive Officer PhRMA Washington, DC |
|